The potential role of neoadjuvant chemotherapy in advanced ovarian cancer
- 1 November 2003
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 13 (s2) , 163-168
- https://doi.org/10.1111/j.1525-1438.2003.13354.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?Gynecologic Oncology, 2002
- Neoadjuvant chemotherapy for advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1996
- Does Aggressive Therapy Improve Survival in Suboptimal Stage IIIc/IV Ovarian Cancer? A Canadian–American Comparative StudyGynecologic Oncology, 1995
- Ovarian carcinoma: value of CT in predicting success of debulking surgery.American Journal of Roentgenology, 1995
- Primary Surgery in Ovarian Cancer: Current OpinionsAnnals of Medicine, 1995
- The Influence of Tumor Grade, Distribution, and Extent of Carcinomatosis in Minimal Residual Stage III Epithelial Ovarian Cancer after Optimal Primary Cytoreductive SurgeryGynecologic Oncology, 1994
- Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancerGynecologic Oncology, 1991
- Neoadjuvant chemotherapy in stage X ovarian carcinomaGynecologic Oncology, 1990
- A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectivesEuropean Journal of Cancer and Clinical Oncology, 1989
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986